Featured Research

from universities, journals, and other organizations

‘SKIP’-ing splicing forces tumor cells to undergo programmed cell death

Date:
April 3, 2011
Source:
Salk Institute
Summary:
When cells find themselves in a tight spot, the cell cycle regulator p21 halts the cell cycle, buying cells time to repair the damage, or if all else fails, to initiate programmed cell death. In contrast to other stress-induced genes, which dispense with the regular transcriptional entourage, p21Cip1 still requires SKIP, a transcription elongation factor that also helps with the editing of transcripts, to be expressed, found researchers.

When cells find themselves in a tight spot, the cell cycle regulator p21 halts the cell cycle, buying cells time to repair the damage, or if all else fails, to initiate programmed cell death. In contrast to other stress-induced genes, which dispense with the regular transcriptional entourage, p21Cip1 still requires SKIP, a transcription elongation factor that also helps with the editing of transcripts, to be expressed, found researchers at the Salk Institute for Biological Studies.

Related Articles


In the absence of SKIP, the expression of p21Cip1 is rapidly down-regulated, predisposing cells to undergo programmed cell death, especially when faced with DNA damage-inducing chemotherapeutic agents. Their findings, reported in the April 1, 2011 issue of Genes & Development, not only define a new step that controls programmed cell death in cancer cells, but also suggest new approaches to enhance the efficacy of chemotherapeutic drugs.

"Interestingly, SKIP levels decline in cells treated with flavopiridol, which is currently in clinical trials as an anticancer agent for leukemia, and as a combination therapy for solid tumors," says Katherine A. Jones, Ph.D., a professor in the Regulatory Biology Laboratory, who led the study. "Our findings might help explain why flavopiridol works so well in combination with other cytotoxic drugs. Loss of SKIP sensitizes cancer cells to the apoptotic effects of DNA damage-inducing anticancer drugs."

The DNA in our cells is under constant attack from reactive chemicals generated as by-products of cellular metabolism. In addition, it is assaulted by x-rays, ultraviolet radiation from the sun, and environmental carcinogens such as tobacco smoke. If a cell suffers non-repairable injury it activates a built-in "auto-destruct" mechanism, known as programmed cell death or apoptosis. It eliminates abnormal cells from the body before they can cause disease, including cancer.

As a first-responder, the transcription factor p53 is called to action when cells experience stressful conditions. Depending on the situation, p53 then turns on genes that halt cell division to allow time for repairs, such as p21Cip1, or when all rescue attempts prove futile, order the cell to commit suicide by turning on pro-apoptotic genes such as PUMA.

"It is the timing and duration of expression of the set of p53 target genes that are turned on, which strongly influences cell fate decisions," says Jones, who likes to compare PUMA, which takes its time to come online, and p21Cip1, which quickly snaps into action in response to damage, to Aesop's fable of the tortoise and the hare. "Cell cycle arrest genes are poised for immediate action, whereas pro-apoptotic genes go slow but steady."

Even before cell damage occurs, these genes differ in the number and composition of their pre-loaded transcription complexes. These multi-protein assemblies, called RNA polymerase II (Pol II), slide along the DNA's double helix, reading the genetic code and transcribing it into RNA, which is used as a blueprint to build proteins, or as a switch to regulate other genes. But Pol II is prone to stalling in the middle of transcribing genes and needs to be prodded along by elongation factors such as SKIP. "Under stressful conditions everything changes," explains Jones. "Elongation factors seem to be no longer necessary for transcription."

But SKIP influences gene expression in more than one way. It also plays an important role during the splicing process, which removes intervening sequences or introns, and joins the remaining pieces or exons to form a mature messenger RNA that can now be used to produce protein.

It is the splicing function that p21Cip1 cannot do without, revealed the experiments by postdoctoral researchers Yupeng Chen, Ph.D., and Lirong Zhang, Ph.D. "SKIP is critical for splicing and expression of p21Cip1, but not for PUMA or any of the other p53-induced genes we looked at in colon cancer and osteosarcoma cells," says Chen. He found that SKIP recruits a critical splice factor to the p21 gene, while the same factor finds its way to the PUMA gene without SKIP's help. As a consequence, the depletion of SKIP induced apoptosis, which was most pronounced in cells subjected to DNA damage.

"Many chemotherapeutic drugs work by inducing apoptosis," says Zhang. "Combining them with small molecules that inhibit splicing of the p21 mRNA may boost their efficiency of forcing tumor cells to undergo programmed cell death."

The work was funded in part by the National Institutes of Health.


Story Source:

The above story is based on materials provided by Salk Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Y. Chen, L. Zhang, K. A. Jones. SKIP counteracts p53-mediated apoptosis via selective regulation of p21Cip1 mRNA splicing. Genes & Development, 2011; 25 (7): 701 DOI: 10.1101/gad.2002611

Cite This Page:

Salk Institute. "‘SKIP’-ing splicing forces tumor cells to undergo programmed cell death." ScienceDaily. ScienceDaily, 3 April 2011. <www.sciencedaily.com/releases/2011/04/110401142855.htm>.
Salk Institute. (2011, April 3). ‘SKIP’-ing splicing forces tumor cells to undergo programmed cell death. ScienceDaily. Retrieved November 24, 2014 from www.sciencedaily.com/releases/2011/04/110401142855.htm
Salk Institute. "‘SKIP’-ing splicing forces tumor cells to undergo programmed cell death." ScienceDaily. www.sciencedaily.com/releases/2011/04/110401142855.htm (accessed November 24, 2014).

Share This


More From ScienceDaily



More Plants & Animals News

Monday, November 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Stray Dog Follows Adventure Racing Team for 6-Day Endurance Race

Stray Dog Follows Adventure Racing Team for 6-Day Endurance Race

Buzz60 (Nov. 24, 2014) A Swedish Adventure racing team travels to try and win a world title, but comes home with something way better: a stray dog that joined the team for much of the grueling 430-mile race. Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com
Deadly Japanese Pufferfish Discovered in Crimean Waters

Deadly Japanese Pufferfish Discovered in Crimean Waters

Reuters - Light News Video Online (Nov. 24, 2014) The capture of deadly Japanese pufferfish in the waters of Crimea is causing concern for fishermen and scientists alike. Sharon Reich reports. Video provided by Reuters
Powered by NewsLook.com
Terrifying Black Seadevil Fish Captured on First-of-Its Kind Video

Terrifying Black Seadevil Fish Captured on First-of-Its Kind Video

Buzz60 (Nov. 24, 2014) An aquarium captures a first-of-its kind video of a notoriously camera-shy fish that’s also not so camera-friendly. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Red Panda Cubs Explore the Bratislava Zoo

Red Panda Cubs Explore the Bratislava Zoo

AFP (Nov. 24, 2014) Four-month old Red Panda twins Pim and Pam still rely on their mother for breast milk at the Bratislava Zoo in Slovakia, but the precocious cubs have begun to branch out to solid foods, as well. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Plants & Animals

Earth & Climate

Fossils & Ruins

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins